Sagent Pharmaceuticals recalled three lots of Vecuronium Bromide for injection, a neuromuscular blocking agent used with general anesthesia to provide muscle relaxation or mechanical ventilation.
The voluntary nationwide recall stems from elevated levels of impurity detected during recent routine quality testing. No adverse events have been reported. However, elevated impurities have the potential to result in neuromuscular blockage in patients with renal failure.
Affected lots were distributed between January and May 2012.
More Articles on Anesthesia:
California Society of Anesthesiologists Elects Dr. Peter Sybert President
Congress Looks at SGR Repeal, Must Also Tackle Anesthesiologists' 33% Problem Prior
FDA Investigates Fungal Infection Associated with Tennessee Compounding Pharmacy
The voluntary nationwide recall stems from elevated levels of impurity detected during recent routine quality testing. No adverse events have been reported. However, elevated impurities have the potential to result in neuromuscular blockage in patients with renal failure.
Affected lots were distributed between January and May 2012.
More Articles on Anesthesia:
California Society of Anesthesiologists Elects Dr. Peter Sybert President
Congress Looks at SGR Repeal, Must Also Tackle Anesthesiologists' 33% Problem Prior
FDA Investigates Fungal Infection Associated with Tennessee Compounding Pharmacy